Nov 13 2013
Codexis, Inc. (NASDAQ: CDXS), a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries. Codexis’ proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing.
Codexis is an international company. We have regionally-based sales representatives across the United States and Europe, as well as production partners in the United States, Europe and India. In addition to our headquarters in Redwood City, California, USA, we have a research and development facility in Budapest, Hungary.
Codexis is a leading developer of biocatalysts. A biocatalyst is an enzyme or microbe that initiates and accelerates a chemical reaction. Our technologies bring improved manufacturing approaches to sectors ranging from the pharmaceutical industry, fine chemicals, flavors and fragrances, to animal health, biofuels, food and nutrition, agrochemicals and carbon capture.
Shutting down the cellulosic enzyme business
Nov 12-2013 John Nicols, President and CEO of Codexis
“Going forward, we will exclusively focus the company onto this biocatalysis business enterprise in which we develop and supply enzymes to reduce the costs and increase the efficiency of our customers’ pharmaceutical and chemical manufacturing processes. Given the market’s undervaluation of the prospects and continued slow build out of cellulosic ethanol facilities, we have not been able to secure a suitable partnership or transaction for our CodeXyme® cellulase enzyme business. Accordingly, we have begun today to immediately wind down our CodeXyme® franchise, after having already stopped further development of our CodeXol® detergent alcohols franchise earlier in the year.”
Headquarters - Redwood City, CA, USA
200 Penobscot Drive, Redwood City, CA 94063
Codexis Laboratories Hungary Kft.
1045 Budapest Berlini utca 47-49